Trial intelligence / Profile preview

Mucutin spray vs benzydamine hydrochloride spray for prevention of radiation-induced acute oral mucositis in head and neck cancer

IRCT20161024030467N1Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Sep 2019
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of benzydamine in stomatitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Incidence of acute oral mucositis. Started Sep 2019; status: completed.

02

Drugs

benzydamine
03

Conditions

stomatitis

Beyond the preview

Go deeper on IRCT20161024030467N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20161024030467N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call